革命藥品公司
US ˙ NasdaqGS ˙ US76155X1000

簡介

本頁面提供了有關 Third Rock Ventures II, L.P. 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言，基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是，他們必須透過Form 4向美國證券交易委員會（SEC）報告所有交易。盡管存在這些限制，學術研究表明，內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易，排除了作為10b5-1交易計劃的一部分的交易。然後，對每筆交易在3、6和12個月的表現進行平均，以生成該筆交易最終的表現指標。最終，將所有交易的表現指標進行平均，計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A"，則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易，或者他們進行的交易距離現在太近，無法計算出可靠的表現指標。

更新頻率：每日

查看收益最高的的內幕交易者列表。

查看排名最高的內部人士。
報告內部持倉的公司

SEC文件顯示Third Rock Ventures II, L.P.已報告在以下公司擁有持倉或進行了交易：

證券 職位 最新報告的持倉
US:JNCE / Jounce Therapeutics Inc 10% Owner 2,697,829
US:RVMD / Revolution Medicines, Inc. 10% Owner 0
10% Owner 885,104
US:ALNA / Allena Pharmaceuticals Inc 10% Owner 0
US:GBT / Global Blood Therapeutics Inc. 10% Owner 2,475,191
US:BPMC / Blueprint Medicines Corporation 10% Owner 3,453,753
US:SAGE / Sage Therapeutics, Inc. 10% Owner 2,892,916
如何解讀這些圖表

以下圖表顯示了在Third Rock Ventures II, L.P.進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如，如果一筆內部人士交易是在2019年1月1日進行的，該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元，則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%，而從10美元跌至5美元的價格變化將為-50%。

最終，我們將評估內部人士的交易與股價的超額回報（正向或負向）之間的相關性，以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為，我們預期看到（a）購買後的正回報，或者（b）賣出後的負回報。對於情況（a），購買圖表將顯示一系列向上傾斜的曲線，表示每次購買後都有正回報。對於情況（b），賣出圖表將顯示一系列向下傾斜的曲線，表示每次賣出後都有負回報。

然而，僅憑這一點還不足以得出結論。例如，如果公司的股價在多年內呈現非周期性上升，我們會預期所有購買後的圖表都呈現向上傾斜。同樣地，多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下，「購買」圖表顯示正向信號，而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易，以獲得財務優勢。

RVMD / Revolution Medicines, Inc.內部人士買入 - 短期收益分析

在這一部分，我們分析了在 RVMD / Revolution Medicines, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報，以及是否值得跟踪。該分析基於每筆交易後一年的情況，結果僅為理論值。

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數		 Reported
價格		 經調整
股數		 經調整
價格		 成本基礎 達到最高利潤的
天數		 達到最高利潤時的
價格		 最高
淨利 ($)		 最高回報率（%）
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

RVMD / Revolution Medicines, Inc. Insider Trades
RVMD / Revolution Medicines, Inc.內部人士賣出 - 短期虧損分析

在這一部分，我們分析了在 RVMD / Revolution Medicines, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式，可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況，

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數		 Reported
價格		 經調整
股數		 經調整
價格		 成本基礎 達到最低利潤的
天數		 達到最低利潤時的
價格		 避免的
最高損失金額($)		 避免的
最高損失率($)
2021-06-04 RVMD Third Rock Ventures II, L.P. 164,996 30.2300 164,996 30.2300 4,987,829 342 14.5400 -2,588,787 -51.90
2021-06-03 RVMD Third Rock Ventures II, L.P. 378,117 30.2000 378,117 30.2000 11,419,133
2021-05-26 RVMD Third Rock Ventures II, L.P. 1,231,204 30.5300 1,231,204 30.5300 37,588,658
2021-05-25 RVMD Third Rock Ventures II, L.P. 135,000 30.9300 135,000 30.9300 4,175,550

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

RVMD / Revolution Medicines, Inc. Insider Trades
歷史內部人交易

該表格顯示了由 Third Rock Ventures II, L.P. 進行的所有內幕交易的完整列表，這些交易已向美國證券交易委員會（SEC）披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化		 每股
股價		 交易
金額		 剩餘
金額
2021-09-17 2021-09-15 4 JNCE Jounce Therapeutics, Inc.
Common Stock 		J - Other X -1,750,000 2,697,829 -39.35
2021-06-14 2021-06-10 4 JNCE Jounce Therapeutics, Inc.
Common Stock 		J - Other X -1,500,000 4,447,829 -25.22
2021-06-07 2021-06-04 4 RVMD Revolution Medicines, Inc.
Common Stock 		S - Sale -164,996 0 -100.00 30.23 -4,987,829
2021-06-07 2021-06-03 4 RVMD Revolution Medicines, Inc.
Common Stock 		S - Sale -378,117 164,996 -69.62 30.20 -11,419,133 4,982,879
2021-05-27 2021-05-25 4 JNCE Jounce Therapeutics, Inc.
Common Stock 		S - Sale -552,520 5,947,829 -8.50 8.00 -4,420,160 47,582,632
2021-05-27 2021-05-26 4 RVMD Revolution Medicines, Inc.
Common Stock 		S - Sale -1,231,204 543,113 -69.39 30.53 -37,588,658 16,581,240
2021-05-27 2021-05-25 4 RVMD Revolution Medicines, Inc.
Common Stock 		S - Sale -135,000 1,774,317 -7.07 30.93 -4,175,550 54,879,625
2021-03-15 2021-03-11 4 JNCE Jounce Therapeutics, Inc.
Common Stock 		J - Other X -1,250,000 6,500,349 -16.13
2021-03-03 2021-03-01 4 JNCE Jounce Therapeutics, Inc.
Common Stock 		S - Sale -1,450,000 7,750,349 -15.76 11.75 -17,037,500 91,066,601
2020-11-23 2020-11-19 4 JNCE Jounce Therapeutics, Inc.
Common Stock 		S - Sale -15,000 9,200,349 -0.16 7.00 -105,075 64,448,445
2020-11-19 2020-11-17 4 JNCE Jounce Therapeutics, Inc.
Common Stock 		S - Sale -15,000 9,215,349 -0.16 7.25 -108,772 66,825,103
2020-11-13 2020-11-11 4 JNCE Jounce Therapeutics, Inc.
Common Stock 		J - Other -1,000,000 9,230,349 -9.77
2020-02-18 2020-02-18 4 RVMD Revolution Medicines, Inc.
Series B Preferred Stock 		C - Conversion -1,909,317 0 -100.00
2020-02-18 2020-02-18 4 RVMD Revolution Medicines, Inc.
Series C Preferred Stock 		C - Conversion -49,879 0 -100.00
2020-02-18 2020-02-18 4 RVMD Revolution Medicines, Inc.
Series B Preferred Stock 		C - Conversion -342,505 0 -100.00
2020-02-18 2020-02-18 4 RVMD Revolution Medicines, Inc.
Series A Preferred Stock 		C - Conversion -8,220,641 0 -100.00
2020-02-18 2020-02-18 4 RVMD Revolution Medicines, Inc.
Common Stock 		C - Conversion 1,909,317 1,909,317
2020-02-18 2020-02-18 4 RVMD Revolution Medicines, Inc.
Common Stock 		C - Conversion 8,613,025 9,024,031 2,095.60
2020-02-12 3 RVMD Revolution Medicines, Inc.
Common Stock 		822,012
2020-02-12 3 RVMD Revolution Medicines, Inc.
Common Stock 		822,012
2020-02-12 3 RVMD Revolution Medicines, Inc.
Common Stock 		822,012
2020-02-12 3 RVMD Revolution Medicines, Inc.
Common Stock 		822,012
2020-02-12 3 RVMD Revolution Medicines, Inc.
Common Stock 		822,012
2020-02-12 3 RVMD Revolution Medicines, Inc.
Common Stock 		822,012
2020-02-12 3 RVMD Revolution Medicines, Inc.
Common Stock 		822,012
2020-02-12 3 RVMD Revolution Medicines, Inc.
Common Stock 		822,012
2020-02-12 3 RVMD Revolution Medicines, Inc.
Common Stock 		822,012
2020-02-12 3 RVMD Revolution Medicines, Inc.
Common Stock 		822,012
2020-02-12 3 RVMD Revolution Medicines, Inc.
Common Stock 		822,012
2018-03-07 2018-03-07 4 MYOK MyoKardia Inc
Common Stock 		J - Other X -2,000,000 885,104 -69.32
2017-12-08 2017-12-06 4 MYOK MyoKardia Inc
Common Stock 		J - Other X -2,000,000 2,885,104 -40.94
2017-11-06 2017-11-06 4 ALNA Allena Pharmaceuticals, Inc.
Series B Preferred Stock 		C - Conversion -4,629,630 0 -100.00
2017-11-06 2017-11-06 4 ALNA Allena Pharmaceuticals, Inc.
Series A Preferred Stock 		C - Conversion -6,122,448 0 -100.00
2017-11-06 2017-11-06 4 ALNA Allena Pharmaceuticals, Inc.
Common Stock 		P - Purchase 215,000 2,790,964 8.35 14.00 3,010,000 39,073,496
2017-11-06 2017-11-06 4 ALNA Allena Pharmaceuticals, Inc.
Common Stock 		C - Conversion 2,575,964 2,575,964
2017-09-29 2017-09-28 4 MYOK MyoKardia Inc
Common Stock 		J - Other X -2,000,000 4,885,104 -29.05
2017-09-27 2017-09-26 4 MYOK MyoKardia Inc
Common Stock 		S - Sale -400,000 6,885,104 -5.49 43.00 -17,200,000 296,059,472
2017-09-27 2017-09-25 4 MYOK MyoKardia Inc
Common Stock 		S - Sale -201,400 7,285,104 -2.69 43.00 -8,660,200 313,259,472
2017-09-12 2017-09-11 4 MYOK MyoKardia Inc
Common Stock 		S - Sale -20,000 57,651 -25.76 44.25 -885,080 2,551,287
2017-09-12 2017-09-08 4 MYOK MyoKardia Inc
Common Stock 		S - Sale -900 7,486,504 -0.01 42.39 -38,149 317,337,932
2017-09-12 2017-09-08 4 MYOK MyoKardia Inc
Common Stock 		S - Sale -200,350 7,487,404 -2.61 41.00 -8,214,350 306,983,564
2017-06-16 2017-06-14 4 GBT Global Blood Therapeutics, Inc.
Common Stock 		J - Other X -1,000,000 2,475,191 -28.78
2017-05-19 2017-05-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock 		J - Other -1,000,000 3,475,191 -22.35
2017-05-19 2017-04-18 4 GBT Global Blood Therapeutics, Inc.
Common Stock 		G - Gift -1,708 163,996 -1.03
2017-05-19 2017-04-11 4 GBT Global Blood Therapeutics, Inc.
Common Stock 		G - Gift -50,000 165,704 -23.18
2017-04-06 2017-04-06 4 GBT Global Blood Therapeutics, Inc.
Common Stock 		J - Other X -2,000,000 4,475,191 -30.89
2017-04-03 2017-03-30 4 MYOK MyoKardia Inc
Common Stock 		J - Other X -850,000 7,687,754 -9.96
2017-03-06 2017-03-02 4 GBT Global Blood Therapeutics, Inc.
Common Stock 		S - Sale -10,900 146,208 -6.94 28.73 -313,146 4,200,410
2017-03-06 2017-03-02 4 GBT Global Blood Therapeutics, Inc.
Common Stock 		S - Sale -7,279 157,108 -4.43 27.69 -201,526 4,349,692
2017-03-06 2017-03-02 4 GBT Global Blood Therapeutics, Inc.
Common Stock 		S - Sale -27,115 164,387 -14.16 26.95 -730,803 4,430,558
2017-03-06 2017-03-02 4 GBT Global Blood Therapeutics, Inc.
Common Stock 		S - Sale -1,000,000 285,713 -77.78 25.50 -25,500,000 7,285,682
2017-03-06 2017-03-02 4 GBT Global Blood Therapeutics, Inc.
Common Stock 		S - Sale -1,000,000 285,713 -77.78 25.50 -25,500,000 7,285,682
2017-02-28 2017-02-27 4 BPMC Blueprint Medicines Corp
Common Stock 		J - Other X -1,000,000 3,453,753 -22.45
2017-02-09 2017-02-07 4 BPMC Blueprint Medicines Corp
Common Stock 		S - Sale -1,000,000 4,453,753 -18.34 35.28 -35,275,000 157,106,137
2017-02-03 2017-02-01 4 JNCE Jounce Therapeutics, Inc.
Series A Preferred Stock 		C - Conversion -11,250,000 0 -100.00
2017-02-03 2017-02-01 4 JNCE Jounce Therapeutics, Inc.
Series A Preferred Stock 		C - Conversion -35,750,000 0 -100.00
2017-02-03 2017-02-01 4 JNCE Jounce Therapeutics, Inc.
Common Stock 		C - Conversion 3,048,780 3,048,780
2017-02-03 2017-02-01 4 JNCE Jounce Therapeutics, Inc.
Common Stock 		C - Conversion 9,688,344 10,230,349 1,787.50
2017-01-26 3 JNCE Jounce Therapeutics, Inc.
Common Stock 		1,084,010
2017-01-26 3 JNCE Jounce Therapeutics, Inc.
Common Stock 		1,084,010
2017-01-26 3 JNCE Jounce Therapeutics, Inc.
Common Stock 		1,084,010
2017-01-26 3 JNCE Jounce Therapeutics, Inc.
Common Stock 		1,084,010
2017-01-26 3 JNCE Jounce Therapeutics, Inc.
Common Stock 		1,084,010
2017-01-26 3 JNCE Jounce Therapeutics, Inc.
Common Stock 		1,084,010
2017-01-26 3 JNCE Jounce Therapeutics, Inc.
Common Stock 		1,084,010
2017-01-26 3 JNCE Jounce Therapeutics, Inc.
Common Stock 		1,084,010
2017-01-26 3 JNCE Jounce Therapeutics, Inc.
Common Stock 		1,084,010
2016-12-16 2016-12-14 4 GBT Global Blood Therapeutics, Inc.
Common Stock 		J - Other X -2,000,000 7,475,191 -21.11
2016-12-01 2016-11-29 4 MYOK MyoKardia Inc
Common Stock 		J - Other X -850,000 8,537,754 -9.05
2016-11-16 2016-11-14 4 GBT Global Blood Therapeutics, Inc.
Common Stock 		S - Sale -1,000,000 1,939,449 -34.02 19.36 -19,360,000 37,547,733
2016-11-16 2016-11-14 4 GBT Global Blood Therapeutics, Inc.
Common Stock 		S - Sale -1,000,000 1,285,713 -43.75 19.36 -19,360,000 24,891,404
2016-11-07 2016-11-03 4 GBT Global Blood Therapeutics, Inc.
Common Stock 		J - Other -2,000,000 10,475,191 -16.03
2016-08-19 2016-08-19 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other -1,000,000 2,892,916 -25.69
2016-05-18 2016-05-16 4 SAGE Sage Therapeutics, Inc.
Common Stock 		S - Sale -850,000 3,892,916 -17.92 31.25 -26,562,500 121,653,625
2016-04-15 2016-04-14 4 BPMC Blueprint Medicines Corp
Common Stock 		J - Other -1,200,000 5,453,753 -18.03
2015-11-18 2015-11-18 4 BPMC Blueprint Medicines Corp
Common Stock 		J - Other 40,290 40,290
2015-11-18 2015-11-18 4 BPMC Blueprint Medicines Corp
Common Stock 		J - Other 40,290 40,290
2015-11-18 2015-11-18 4 BPMC Blueprint Medicines Corp
Common Stock 		J - Other 40,290 40,290
2015-11-18 2015-11-18 4 BPMC Blueprint Medicines Corp
Common Stock 		J - Other -220,387 0 -100.00
2015-11-18 2015-11-18 4 BPMC Blueprint Medicines Corp
Common Stock 		J - Other 220,387 220,387
2015-11-18 2015-11-18 4 BPMC Blueprint Medicines Corp
Common Stock 		J - Other -739,306 6,653,753 -10.00
2015-11-13 2015-11-12 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other 15,986 65,227 32.46
2015-11-13 2015-11-12 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other 15,986 65,227 32.46
2015-11-13 2015-11-12 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other -109,832 0 -100.00
2015-11-13 2015-11-12 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other 109,832 109,832
2015-11-13 2015-11-12 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other -1,700,000 4,742,916 -26.39
2015-11-05 2015-11-03 4 MYOK MyoKardia Inc
Series A Preferred Stock 		C - Conversion -5,500,000 0 -100.00
2015-11-05 2015-11-03 4 MYOK MyoKardia Inc
Series A Preferred Stock 		C - Conversion -32,500,000 0 -100.00
2015-11-05 2015-11-03 4 MYOK MyoKardia Inc
Common Stock 		C - Conversion 1,496,598 1,496,598
2015-11-05 2015-11-03 4 MYOK MyoKardia Inc
Common Stock 		C - Conversion 8,843,537 9,387,754 1,625.00
2015-10-28 3 MYOK MyoKardia Inc
Common Stock 		1,088,434
2015-10-28 3 MYOK MyoKardia Inc
Common Stock 		1,088,434
2015-10-28 3 MYOK MyoKardia Inc
Common Stock 		1,088,434
2015-10-28 3 MYOK MyoKardia Inc
Common Stock 		1,088,434
2015-10-28 3 MYOK MyoKardia Inc
Common Stock 		1,088,434
2015-10-28 3 MYOK MyoKardia Inc
Common Stock 		1,088,434
2015-10-28 3 MYOK MyoKardia Inc
Common Stock 		1,088,434
2015-10-28 3 MYOK MyoKardia Inc
Common Stock 		1,088,434
2015-10-28 3 MYOK MyoKardia Inc
Common Stock 		1,088,434
2015-08-19 2015-08-17 4 GBT Global Blood Therapeutics, Inc.
Series A Preferred Stock 		C - Conversion -41,663,168 0 -100.00
2015-08-19 2015-08-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock 		C - Conversion 11,903,763 12,475,191 2,083.16
2015-08-18 2015-08-18 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other 21,910 49,241 80.17
2015-08-18 2015-08-18 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other 21,910 49,241 80.17
2015-08-18 2015-08-18 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other -150,546 0 -100.00
2015-08-18 2015-08-18 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other 150,546 150,546
2015-08-18 2015-08-18 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other -2,330,157 6,442,916 -26.56
2015-08-11 3 GBT Global Blood Therapeutics, Inc.
Common Stock 		1,142,856
2015-08-11 3 GBT Global Blood Therapeutics, Inc.
Common Stock 		1,142,856
2015-08-11 3 GBT Global Blood Therapeutics, Inc.
Common Stock 		1,142,856
2015-08-11 3 GBT Global Blood Therapeutics, Inc.
Common Stock 		1,142,856
2015-08-11 3 GBT Global Blood Therapeutics, Inc.
Common Stock 		1,142,856
2015-08-11 3 GBT Global Blood Therapeutics, Inc.
Common Stock 		1,142,856
2015-08-11 3 GBT Global Blood Therapeutics, Inc.
Common Stock 		1,142,856
2015-08-11 3 GBT Global Blood Therapeutics, Inc.
Common Stock 		1,142,856
2015-08-11 3 GBT Global Blood Therapeutics, Inc.
Common Stock 		1,142,856
2015-06-22 2015-06-19 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other 9,403 27,331 52.45
2015-06-22 2015-06-19 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other 9,402 27,330 52.44
2015-06-22 2015-06-19 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other -64,607 0 -100.00
2015-06-22 2015-06-19 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other 64,607 64,607
2015-06-22 2015-06-19 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other -1,000,000 8,773,073 -10.23
2015-05-12 2015-05-05 4 BPMC Blueprint Medicines Corp
Series C Preferred Stock 		C - Conversion -1,328,502 0 -100.00
2015-05-12 2015-05-05 4 BPMC Blueprint Medicines Corp
Series B Preferred Stock 		C - Conversion -7,833,333 0 -100.00
2015-05-12 2015-05-05 4 BPMC Blueprint Medicines Corp
Series A Preferred Stock 		C - Conversion -30,000,000 0 -100.00
2015-05-12 2015-05-05 4 BPMC Blueprint Medicines Corp
Common Stock 		C - Conversion 241,545 7,393,059 3.38
2015-05-12 2015-05-05 4 BPMC Blueprint Medicines Corp
Common Stock 		C - Conversion 1,424,242 7,151,514 24.87
2015-05-12 2015-05-05 4 BPMC Blueprint Medicines Corp
Common Stock 		C - Conversion 5,454,545 5,727,272 2,000.00
2015-04-29 3 BPMC Blueprint Medicines Corp
Common Stock 		545,454
2015-04-29 3 BPMC Blueprint Medicines Corp
Common Stock 		545,454
2015-04-29 3 BPMC Blueprint Medicines Corp
Common Stock 		545,454
2015-04-29 3 BPMC Blueprint Medicines Corp
Common Stock 		545,454
2015-04-29 3 BPMC Blueprint Medicines Corp
Common Stock 		545,454
2015-04-29 3 BPMC Blueprint Medicines Corp
Common Stock 		545,454
2015-04-29 3 BPMC Blueprint Medicines Corp
Common Stock 		545,454
2015-01-28 2015-01-27 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other -81,094 0 -100.00
2015-01-28 2015-01-27 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other 81,094 81,094
2015-01-28 2015-01-27 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other -1,255,177 9,773,073 -11.38
2015-01-20 2015-01-16 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other -42,173 0 -100.00
2015-01-20 2015-01-16 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other 42,173 42,173
2015-01-20 2015-01-16 4 SAGE Sage Therapeutics, Inc.
Common Stock 		J - Other -652,758 11,028,250 -5.59
2014-07-23 2014-07-23 4 SAGE Sage Therapeutics, Inc.
Series C Preferred Stock 		C - Conversion -295,194 0 -100.00
2014-07-23 2014-07-23 4 SAGE Sage Therapeutics, Inc.
Series B Preferred Stock 		C - Conversion -2,499,999 0 -100.00
2014-07-23 2014-07-23 4 SAGE Sage Therapeutics, Inc.
Series A Preferred Stock 		C - Conversion -32,500,000 0 -100.00
2014-07-23 2014-07-23 4 SAGE Sage Therapeutics, Inc.
Common Stock 		C - Conversion 93,712 11,681,008 0.81
2014-07-23 2014-07-23 4 SAGE Sage Therapeutics, Inc.
Common Stock 		C - Conversion 793,650 11,587,296 7.35
2014-07-23 2014-07-23 4 SAGE Sage Therapeutics, Inc.
Common Stock 		C - Conversion 10,317,457 10,793,646 2,166.67
2014-07-17 3 SAGE Sage Therapeutics, Inc.
Common Stock 		952,378
2014-07-17 3 SAGE Sage Therapeutics, Inc.
Common Stock 		952,378
2014-07-17 3 SAGE Sage Therapeutics, Inc.
Common Stock 		952,378
2014-07-17 3 SAGE Sage Therapeutics, Inc.
Common Stock 		952,378
2014-07-17 3 SAGE Sage Therapeutics, Inc.
Common Stock 		952,378
2014-07-17 3 SAGE Sage Therapeutics, Inc.
Common Stock 		952,378
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券（例如股票期權）
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券（例如期權）
V
內部人士透過Form 4自願報告的一筆交易
J
其他（附有交易描述的腳註）